[Federal Register Volume 79, Number 154 (Monday, August 11, 2014)]
[Notices]
[Page 46827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-18940]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-14-14ARJ]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC), as part of 
its continuing effort to reduce public burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995. To request more information on the 
below proposed project or to obtain a copy of the information 
collection plan and instruments, call 404-639-7570 or send comments to 
Leroy Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send 
an email to [email protected].
    Comments submitted in response to this notice will be summarized 
and/or included in the request for Office of Management and Budget 
(OMB) approval. Comments are invited on: (a) Whether the proposed 
collection of information is necessary for the proper performance of 
the functions of the agency, including whether the information shall 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden of the proposed collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information to be 
collected; (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information. Burden 
means the total time, effort, or financial resources expended by 
persons to generate, maintain, retain, disclose or provide information 
to or for a Federal agency. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. Written comments should be received within 60 
days of this notice.

Proposed Project

    Clinic Context Matters Study-New-National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The daily use of specific antiretroviral medications by persons 
without HIV infection, but at high risk of sexual or injection exposure 
to HIV, has been shown to be a safe and effective HIV prevention 
method. The Food and Drug Administration approved the use of 
Truvada[supreg] for preexposure prophylaxis (PrEP) in July 2012 and CDC 
has issued Public Health Service clinical practice guidelines for its 
use. Because approximately 50,000 new HIV infections continue to occur 
each year, with rates of HIV infection increasing most rapidly for 
young MSM and because severe disparities in HIV infection continue 
among African-American men and women, incorporation of PrEP into HIV 
prevention is important. However, as a prevention tool in very early 
stages of introduction and use, there is much we need to learn about 
how to implement PrEP in a real-world setting.
    CDC is requesting OMB approval to collect data over a 3-year period 
that will be used to conduct research among clinicians about their 
knowledge, attitudes, and practices related to a new intervention 
(PrEP) over the period of its initial introduction in their clinics. 
The knowledge gained will be used to refine measurement instruments and 
methods (for example, identify modifications to questions in the 
current surveys that are unclear to participants), develop training and 
educational resources and tools for use by CDC/DHAP (Division of HIV/
AIDS Prevention)-funded partners, and other organizations supporting 
delivery of PrEP in clinical settings.
    The project will be conducted in clinics in each of four cities 
(Houston, Newark, Chicago, and Philadelphia) where PrEP has recently 
become available through a local community health center.
    Once per year for 3 years, CDC will conduct an online survey of 
clinicians at participating clinics to collect data on the demographics 
of the respondents and their knowledge, attitudes, practices, and 
organizational factors related to PrEP and its delivery in their 
clinics. Surveys will be administered through an online survey Web 
site.
    There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of                         Total
      Type of respondent            Form name        Number of     responses per   Average hours     response
                                                    respondents     respondent     per response    burden hours)
----------------------------------------------------------------------------------------------------------------
Clinician.....................  Clinician                    175               1           30/60              88
                                 Consent and
                                 Interview.
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............              88
----------------------------------------------------------------------------------------------------------------


Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-18940 Filed 8-8-14; 8:45 am]
BILLING CODE 4163-18-P